Hoppa till innehål
banner-mesenkia-8

Welcome to our Investor Sessions

November 17, 2026

We are pleased to invite you to one of our four investor sessions, where you will have the opportunity to meet our CEO, the team and learn more about our groundbreaking antibody technology, recent progress, and exciting collaborations.

Above all, you will have the opportunity to ask questions, engage directly with our team, and gain a deeper understanding of our company and the investment opportunity.

We have designed these sessions to be small and personal, creating an environment for conversations, open discussions, and valuable dialogues.

Choose the date that works best for you:

  • December 10, 8:30–10:00 AM| Breakfast
  • December 16, 1:00–2:30 PM| Afternoon Coffee
  • January 13, 9:00–10:30 AM| Breakfast
  • January 15, 3:30–5:00 PM| Afternoon Coffee

Register here:

https://tally.so/r/5Xjx4Z

Location: Mesenkia Therapeutics, Majoren, Dag Hammarskjölds väg 26, Uppsala, Sweden

Contact: Jenny Lundell, Business Development & IR: jenny.lundell@mesenkia.com

We are looking forward meeting you, Welcome!

 

More news

Meet our CEO and learn more about our groundbreaking antibody technology and investment opportunity in one of our four investor ...

BioArctic AB (publ) (Nasdaq Stockholm: BIOA B) and Mesenkia Therapeutics announced today that the companies have signed a research collaboration ...

Researchers have identified HVEM as a promising therapeutic target in mesenchymal glioblastoma...